EYPT Eyepoint, Inc.
Healthcare · Laboratory Analytical Instruments
Eyepoint, Inc. (EYPT) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $1.1 billion. Shares last traded at $13.59, 31.0% below their 52-week high. Over the past year the stock is up 54.2%. Net profit margin is -739.4%, below the peer median of -1.5%. Revenue declined 27.5% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $-0.99 | 2026-05-07 |
| FY 2025 | $-3.17 | 2026-03-05 |
| Q3 2025 | $-2.35 | 2025-11-06 |
| Q2 2025 | $-1.50 | 2025-08-07 |
| Q1 2026 | $-0.65 | 2026-05-07 |
| FY 2025 | $-2.32 | 2026-03-05 |
Laboratory Analytical Instruments peers
EYPT vs 14 industry peers (Laboratory Analytical Instruments), by market cap.
| A | Agilent Technologies | $35.9B | 27.55 | 5.17 | 18.8% | +2.23% |
| WAT | Waters Corporation | $34.9B | 54.32 | 11.03 | 20.3% | -0.44% |
| ILMN | Illumina, Inc. | $24.5B | 28.80 | 5.64 | 19.6% | +1.68% |
| MTD | Mettler Toledo | $23.1B | 26.59 | 5.74 | 21.6% | +1.22% |
| RVTY | Revvity | $11.1B | 46.22 | 3.90 | 8.4% | +2.23% |
| BRKR | Bruker Corp | $8.7B | -1049.06 | 2.53 | -0.2% | +4.51% |
| BIO | Bio-Rad Laboratories, Inc. | $7.6B | 10.02 | 2.95 | 29.4% | -0.80% |
| AVTR | Avantor, Inc. | $6.5B | -12.32 | 1.00 | -8.1% | +1.16% |
| TXG | 10x Genomics, Inc. | $4.5B | -102.51 | 6.94 | -6.8% | +8.24% |
| ALMR | Alamar Biosciences, Inc. | $1.5B | — | — | — | +8.56% |
| EYPT | Eyepoint, Inc. | $1.1B | -4.91 | — | — | +3.35% |
| CTKB | Cytek Biosciences, Inc. | $488M | -7.34 | 2.42 | -33.0% | -4.91% |
| PACB | Pacific Biosciences Of California, Inc. | $432M | -0.79 | — | — | +3.35% |
| LAB | STANDARD BIOTOOLS INC. | $324M | -4.32 | 3.79 | -87.8% | +2.65% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.